ArticleRenal failure2025
Impact of fluid creep on volume and chloride load in critically ill adults: a prospective study on its prognostic significance and association with MAKE30.
Article in Renal failure, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo quantify ICU fluids for different uses, identify significant fluid sources for volume and chloride load in critically ill adults, and analyze their impact on prognosis.
methodsA prospective study was conducted in a 52-bed academic ICU. From May to December 2022, volume intake/output and fluid purpose were recorded for 5 days for all admitted patients. Fluids were categorized into five types. Patients were divided into high and low fluid creep groups by median dosage. Logistic regression was used to analyze the association with Major Adverse Kidney Events by 30 days (MAKE30).
results1,633 adult critically ill patients with a median age of 67 years and an APACHE II score of 22 were included. Fluid creep, with a median of 802 ml, accounted for 48.4% of daily fluid volume, far more than resuscitation (8.6%) or maintenance/replacement fluid (6.7%). After adjustment for confounders, high fluid creep was associated with a higher incidence of MAKE30 (OR = 1.37) and its components, including in-hospital mortality (OR = 1.49), new renal replacement therapy (OR = 1.83), and persistent renal damage (OR = 1.75).
conclusionsFluid creep is an important source of volume and chloride load in critically ill adults, and high volumes are associated with a higher incidence of MAKE30. Intravenous fluid therapy should be used with caution.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.